| Literature DB >> 25076855 |
Yong Huang1, Feng Dong1, Qian Du1, Hongling Zhang1, Xiaomao Luo1, Xiangjun Song1, Xiaomin Zhao1, Wenlong Zhang1, Dewen Tong1.
Abstract
The indolizidine alkaloid swainsonine (SW) has been reported to impair placentae and ultimately cause abortion in pregnant goats. Up to now, however, the precise effects of SW on goat trophoblast cells (GTCs) are still unclear. In this study, the cytotoxicity effects of SW on GTCs were detected and evaluated by MTT assay, AO/EB double staining, DNA fragmentation assay and flow cytometry analysis. Results showed that SW treatment significantly suppressed GTCs viability and induced typical apoptotic features in a time- and concentration-dependent manner. SW treatment increased Bax protein levels, reduced Bcl-2 protein levels, induced Bax translocation to mitochondria, and triggered the release of cytochrome c from mitochondria into cytosol, which in turn activated caspase-9 and caspase-3, and cleaved PARP, resulting in GTCs apoptosis. However, caspase-8 activity and the level of Bid did not exhibit significant changes in the process of SW-induced apoptosis. In addition, TUNEL assay suggested that SW induced GTCs apoptosis but not other cells in goat placenta cotyledons. Taken together, these data suggest that SW selectively induces GTCs apoptosis via the activation of mitochondria-mediated apoptosis pathway in goat placenta cotyledons, which might contribute to placentae impairment and abortion in pregnant goats fed with SW-containing plants. These findings may provide new insights to understand the mechanisms involved in SW-caused goat's abortion.Entities:
Keywords: abortion.; apoptosis; caspase; goat trophoblast cells; mitochondrial pathway; swainsonine
Mesh:
Substances:
Year: 2014 PMID: 25076855 PMCID: PMC4115199 DOI: 10.7150/ijbs.9168
Source DB: PubMed Journal: Int J Biol Sci ISSN: 1449-2288 Impact factor: 6.580
Fig 1GTCs viability was determined by MTT assay. (A) GTCs were treated with 2.4 μg/mL of SW for indicated times (0-48 hr). (B) GTCs were treated with indicated concentrations (0-4.0 μg/mL) of SW for 24 hr. Results were expressed as percent of untreated control cells (0 μg/mL of SW). The data are mean ± SEM and mean values of three independent experiments. * p < 0.05, ** p < 0.01 versus the control cells.
Fig 2SW treatment induced GTCs apoptosis. (A) Morphological changes under fluorescence microscopy after AO/EB staining. Normal and early apoptotic cells were stained by AO and showed green fluorescence, while late apoptotic cells were stained by EB and showed red fluorescence. Arrows indicate condensed chromatin and nuclear fragmentation. Data shown are representative for three independent experiments. (B) SW induced DNA fragmentation in GTCs. DNA isolated from SW-treated cells was subjected to 2% agarose gel electrophoresis, followed by visualization of bands and photography. Data shown are representative for three independent experiments. (C) Flow cytometry analysis of SW induced apoptosis. The Annexin V-staining cells represent total apoptosis cells. The results are mean ± SEM and mean values of three independent experiments. * p < 0.05, ** p < 0.01 versus the 0 hr cells or 0 μg/mL of SW treated cells.
Fig 3Effects of SW treatment on caspases activation and PARP cleavage in GTCs. (A) Caspase activities in SW treated GTCs. The lysates of 2.4 μg/mL of SW treated cells for indicated times were adjusted to equal protein amounts using the BCA assay and the enzymatic activities of caspases-8, -9, and -3 were measured using the colorimetric assay kits. The results are mean ± SEM and mean values of three independent experiments. * p < 0.05, ** p < 0.01 versus the respective control group (0 hr). (B) GTCs were treated with 2.4 μg/mL of SW for indicated times, then lysed and subjected to western blot analysis to detect total and activated caspase-8, -9, -3 and PARP. The data shown are representative for three independent experiments. (C) Effects of caspase inhibitors on SW-induced GTCs apoptosis. GTCs were incubated with 20 μmol/L of caspase inhibitors for 2 hr prior to 2.4 μg/mL of SW treatment for 24 hr. ** p < 0.01 versus the SW-treated cells without inhibitors. The data shown are mean ± SEM and mean values of three independent experiments. (D) Effects of caspase inhibitors on SW-induced caspase-3 activation in GTCs. GTCs were incubated with 20 μmol/L of caspase inhibitors for 2 hr prior to 2.4 μg/mL of SW treatment for 24 hr. The results are mean ± SEM and mean values of three independent experiments. ** p < 0.01 versus the SW-treated cells without inhibitors.
Fig 4SW induced GTCs apoptosis via activation of mitochondrial pathway. (A, B) SW treatment did not promote the cleavage of Bid, but increased the ratio of Bax/Bcl-2. The values were calculated from the bands corresponding to Bax and Bcl-2 that normalized to β-actin. (C) SW treatment induced Bax translocation and cytochrome c release. GTCs were treated with 2.4 μg/mL of SW for the indicated times. The cytosolic and mitochondrial fraction proteins were collected and then detected by western blot. COX IV and β-actin were used as internal controls for the mitochondrial fractions and the cytosolic fraction, respectively. All the data shown are representative for three independent experiments.
Fig 5Detection of apoptotic GTCs in SW-treated goat placenta cotyledons by TUNEL assay. GTCs were labeled with cytokeratin 7 antibody (green) and all cells were stained with DAPI (blue). Merged images showed TUNEL positive (red) cells primarily occurred on GTCs of SW-treated goat placenta cotyledons (200×). The data are representative for three independent experiments.